Development of LC–MS method for analysis of paclitaxel-inhibited growth and enhanced therapeutic response in human glioblastoma cells
Chinese Chemical Letters(2015)
摘要
Paclitaxel usually binds to microtubules of SU3 glioma cells, and thus enhanced the cytotoxic response of SU3 glioma cells to temozolomide. This study developed a LC–MS platform to reveal the molecular mechanism of paclitaxel-inhibited growth and enhanced therapeutic response in the chemotherapy for glioma multiforme.
更多查看译文
关键词
LC–MS,Drug analysis,SU3 glioma cell,Paclitaxel,Cell cycle arrest,ROS assay
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要